Assessing drug distribution in tissues expressing P-glycoprotein through physiologically based pharmacokinetic modeling: model structure and parameters determination
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4682
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Assessing drug distribution in tissues expressing P-glycoprotein through physiologically based pharmacokinetic modeling: model structure and parameters determination ; volume:6 ; number:1 ; day:15 ; month:1 ; year:2009 ; pages:1-13 ; date:12.2009
Theoretical biology and medical modelling ; 6, Heft 1 (15.1.2009), 1-13, 12.2009
- Urheber
-
Fenneteau, Frédérique
Turgeon, Jacques
Couture, Lucie
Michaud, Véronique
LI, Jun
Nekka, Fahima
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1742-4682-6-2
- URN
-
urn:nbn:de:101:1-2021082322053878490196
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Fenneteau, Frédérique
- Turgeon, Jacques
- Couture, Lucie
- Michaud, Véronique
- LI, Jun
- Nekka, Fahima
- SpringerLink (Online service)
Ähnliche Objekte (12)
Zosuquidar restores drug sensitivity in P-glycoprotein expressing acute myeloid leukemia (AML)
ERBB and P-glycoprotein inhibitors break resistance in relapsed neuroblastoma through P-glycoprotein
P-glycoprotein transporter in drug development
siRNA-based targeting of antiapoptotic genes can reverse chemoresistance in P-glycoprotein expressing chondrosarcoma cells
Inhibition of P-glycoprotein by two artemisinin derivatives
Cytotoxicity and P-glycoprotein inhibition by cardiotonic steroids
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Human physiologically based pharmacokinetic model for propofol
Decreased blood-brain barrier P-glycoprotein function with aging
Regulation of P-glycoprotein at the blood-brain barrier
Regulation of P-glycoprotein at the blood-brain barrier
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Zosuquidar restores drug sensitivity in P-glycoprotein expressing acute myeloid leukemia (AML)
ERBB and P-glycoprotein inhibitors break resistance in relapsed neuroblastoma through P-glycoprotein
P-glycoprotein transporter in drug development
siRNA-based targeting of antiapoptotic genes can reverse chemoresistance in P-glycoprotein expressing chondrosarcoma cells
Inhibition of P-glycoprotein by two artemisinin derivatives
Cytotoxicity and P-glycoprotein inhibition by cardiotonic steroids
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Human physiologically based pharmacokinetic model for propofol
Decreased blood-brain barrier P-glycoprotein function with aging
Regulation of P-glycoprotein at the blood-brain barrier
Regulation of P-glycoprotein at the blood-brain barrier
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Zosuquidar restores drug sensitivity in P-glycoprotein expressing acute myeloid leukemia (AML)
ERBB and P-glycoprotein inhibitors break resistance in relapsed neuroblastoma through P-glycoprotein
P-glycoprotein transporter in drug development
siRNA-based targeting of antiapoptotic genes can reverse chemoresistance in P-glycoprotein expressing chondrosarcoma cells
Inhibition of P-glycoprotein by two artemisinin derivatives
Cytotoxicity and P-glycoprotein inhibition by cardiotonic steroids
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Human physiologically based pharmacokinetic model for propofol
Decreased blood-brain barrier P-glycoprotein function with aging
Regulation of P-glycoprotein at the blood-brain barrier
Regulation of P-glycoprotein at the blood-brain barrier